Music and non-music approaches in psilocybin-assisted psychotherapy: The sound of silence
Sara G. Gloeckler, Julien Thibault Lévesque, Alexandre Lehmann, Houman Farzin, Kyle T. Greenway
Journal of Psychedelic Studies May 15, 2025 DOI: 10.1556/2054.2024.00421 via OpenAlex
Summary
AI-generated from the abstractMusic is a standard part of psilocybin-assisted psychotherapy, but the role of silence is not well understood. In a compassionate-access program in Canada, two breast cancer patients undergoing psilocybin therapy experienced a 30-minute silent period that included mindfulness exercises and therapist discussion. One patient initially found the absence of music difficult but later found the mindfulness exercises highly meaningful. The other patient reported that music had evoked challenging memories early in the session, which were then productively explored during the silent period. The findings suggest that integrating silent intervals may enhance mindfulness and therapist-patient interactions, offering distinct therapeutic benefits. The authors call for more detailed reporting on session components in psychedelic research.
Study at a glance
| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 2 |
| Population | Breast cancer patients undergoing psilocybin therapy under Canada's compassionate access program |
| Interventions | psilocybin therapy intentional periods without music mindfulness exercises |
| Duration | 30-min silent period |
| Topics | Psilocybin |
| Keywords | Silence Sound geography Music therapy Psychology |
| Citations | 3 |
| Key finding | Integrating silent intervals in psilocybin-assisted psychotherapy can enhance mindfulness practices and therapist-patient interactions, potentially offering distinct therapeutic benefits. |
Abstract
Abstract Music is integral to Psilocybin-assisted psychotherapy (PAP), believed to enhance therapeutic outcomes by structuring experiences and facilitating emotional expression. However, the effects of conducting PAP without music are underexplored. This study examines the experiences of two breast cancer patients undergoing psilocybin therapy under Canada's compassionate access program, specifically focusing on sessions that incorporated intentional periods without music. Patients had previously experienced psychedelics in therapeutic contexts but only with continuous music, as is common practice. Here, each patient participated in a 30-min silent period involving mindfulness exercises and therapist discussions. These periods of relative silence resulted in both challenges and benefits. One patient found that the absence of music was difficult initially, but that the relative silence allowed for engagement with mindfulness exercises that were experienced as highly meaningful. The other patient reported that music had evoked challenging past memories early in the dosing session, which were then productively explored with her guides during the subsequent period without music. These findings suggest that integrating silent intervals in PAP can enhance mindfulness practices and therapist-patient interactions, potentially offering distinct therapeutic benefits. Further research is necessary to delineate the differential impacts of music, silence, and guided activities in PAP, given that these three common treatment activities can be understood as both complementary and competing. Finally, we emphasize the importance of more detailed reporting on session components in psychedelic research publications, particularly regarding the balance between patients listening to music and interacting with their guides, which is often not clearly detailed in existing studies.